TCL Archive Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent June 21, 2013
TCL Archive NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests June 5, 1992
TCL Archive In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End November 26, 1999